3Miwa H, Sakaki N, Sugano K, et al. Recurrenl peplic ulcers in patients following successful helicobamer pylori eradication: A multicenter study of 4940 patients. Helicobaeter, 2004,9: 9-16.
4Yamada T, David H, I.oren A, et al. Textbook of gastroenterology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2003.
5Ando T, Minami M, Mizuno T, el al. I.ong term follow up after eradication of helicobacter pylori with Omeprazole, Clarithromycin, and Tinidazole (OCT Regimen) in a Japanese population. Helicobacter,2005,10: 379-384.
6Gisbert JP, Khorrami S, Carballo F, et al. Meta analysis: Helicobacter pylori eradication therapy vs. antisecretory noneradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther, 2004, 19: 617-629.
7Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol, 2005,100: 2083 2099.
8Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: Meta-analysis of 13C-Urea breath test follow up after eradication. Helicobacter, 2008,13:56-61.
9Manuel D, Cutler A, Goldstein J, et al. Decreasing prevalence combined whh increasing eradication of Helieobaeter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther,2007,25:1423-1427.
10Chan K, Wong WV, Suen YB, et al. Combination of a cyclo oxygenase 2 inhibitor and a proton pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double blind, randomised trial. Lancet, 2007, 369: 1621-1626.
